Clinical Trial Update: Phase II/III Study of AR882 Capsules Compared to Febuxostat Tablets in Patients with Primary Gout and Hyperuricemia [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial is evaluating AR882 capsules versus febuxostat tablets in adults with primary gout and hyperuricemia; the study is currently active b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Hyperuricemia

Drugs mentioned

• AR882
• FEBUXOSTAT (Febuxostat)

Snippet

Sponsor: Guangzhou Ruianbo Pharmaceutical Technology Co., Ltd | Conditions: Primary Gout, Hyperuricemia | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING